Immediate Impact

3 by Nobel laureates 1 from Science/Nature 56 standout
Sub-graph 1 of 21

Citing Papers

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
3 intermediate papers

Works of Jose Estevam being referenced

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
2014
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
2012

Author Peers

Author Last Decade Papers Cites
Jose Estevam 550 608 350 16 731
PR Greipp 407 569 284 12 627
RA Kyle 537 537 295 17 819
K. Martin Kortuem 650 544 269 20 829
JP Fermand 279 500 289 16 607
Lorenz Kleeberg 386 365 352 16 661
Valeria Magarotto 650 549 337 29 814
Masaharu Nobuyoshi 418 376 298 20 702
Loredana Santo 374 447 321 23 619
Luis Palomera 451 578 338 25 652
Claudius Rudin 345 487 522 16 829

All Works

Loading papers...

Rankless by CCL
2026